Prevalence of refractory and unexplained chronic cough in adults treated in cough centre
- PMID: 39319047
- PMCID: PMC11417602
- DOI: 10.1183/23120541.00254-2024
Prevalence of refractory and unexplained chronic cough in adults treated in cough centre
Abstract
Background: Refractory chronic cough and unexplained chronic cough pose significant clinical challenges, impairing patients' quality of life. However, a precise definition of refractory chronic cough remains elusive. This study aimed to assess the prevalence of refractory and unexplained chronic cough among patients referred to our cough centre and to analyse the prevalence of refractory chronic cough relative to its definition.
Methods: This prospective cohort study included all patients who were diagnosed at a cough clinic between 2018 and 2022. The response to therapy was measured based on reduction in cough severity (via a visual analogue scale) and improvement in cough-related quality of life (via the Leicester Cough Questionnaire). Refractory chronic cough was defined as persistent cough severity, with no or minimal improvement (change in visual analogue scale <30 mm) after two or more treatment attempts and cough severity ≥40 out of 100 mm on the visual analogue scale.
Results: Of 201 patients treated for chronic cough, only three (1.5%) were diagnosed with unexplained chronic cough. Among 166 patients monitored for therapy response, 71 (42.8%) experienced a cough severity reduction of ≥30 mm on the visual analogue scale, while 100 (60.2%) showed an improvement of ≥1.5 points on the Leicester Cough Questionnaire. Based on the basic refractory chronic cough definition, 51 of 166 patients (30.7%) were diagnosed with refractory chronic cough. If applying stricter criteria (persistent severe cough (≥40 mm on the visual analogue scale), insufficient therapy response (<30 mm reduction on the visual analogue scale) and <1.5-point improvement on the Leicester Cough Questionnaire), 45 of 166 patients (27.1%) would be diagnosed with refractory chronic cough.
Conclusions: Refractory chronic cough is common in patients referred to cough clinics. The prevalence of refractory chronic cough differs slightly depending on the diagnostic criteria. Therefore, the definition of refractory chronic cough used in routine practice needs to be clarified.
Copyright ©The authors 2024.
Conflict of interest statement
Conflict of interest: All authors declare no conflict of interest related to the manuscript.
Figures
Similar articles
-
Speech and language therapy for management of chronic cough.Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD013067. doi: 10.1002/14651858.CD013067.pub2. Cochrane Database Syst Rev. 2019. PMID: 31335963 Free PMC article.
-
Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough.Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221099737. doi: 10.1177/17534666221099737. Ther Adv Respir Dis. 2022. PMID: 35614875 Free PMC article. Clinical Trial.
-
Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study.Lung. 2024 Apr;202(2):97-106. doi: 10.1007/s00408-024-00674-6. Epub 2024 Feb 27. Lung. 2024. PMID: 38411774
-
Blood eosinophils as a predictor of treatment response in adults with difficult-to-treat chronic cough.ERJ Open Res. 2021 Nov 15;7(4):00432-2021. doi: 10.1183/23120541.00432-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34853786 Free PMC article.
-
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.Appl Health Econ Health Policy. 2023 Jan;21(1):119-130. doi: 10.1007/s40258-022-00770-9. Epub 2022 Nov 2. Appl Health Econ Health Policy. 2023. PMID: 36319945 Free PMC article. Review.
Cited by
-
Association of throat sensation severity with quality of life in patients with chronic cough.J Thorac Dis. 2025 Jul 31;17(7):4672-4680. doi: 10.21037/jtd-2024-1994. Epub 2025 Jul 25. J Thorac Dis. 2025. PMID: 40809204 Free PMC article.
-
Disease finds its identity with treatment in the real world: the use of gefapixant in chronic cough.ERJ Open Res. 2025 Jul 7;11(4):00096-2025. doi: 10.1183/23120541.00096-2025. eCollection 2025 Jul. ERJ Open Res. 2025. PMID: 40630383 Free PMC article.
-
The McMaster Cough Severity Questionnaire (MCSQ): a cough severity instrument for patients with refractory chronic cough.Eur Respir J. 2025 Feb 6;65(2):2401565. doi: 10.1183/13993003.01565-2024. Print 2025 Feb. Eur Respir J. 2025. PMID: 39362666 Free PMC article.
-
How Will a Treatable Traits Approach Reshape Clinical Practice in Chronic Cough?Allergy Asthma Immunol Res. 2025 May;17(3):304-316. doi: 10.4168/aair.2025.17.3.304. Allergy Asthma Immunol Res. 2025. PMID: 40414808 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources